🇺🇸 FDA
Patent

US 6410594

Substituted cyclopentane compounds useful as neuraminidase inhibitors

expired A61PA61P31/00A61P31/16

Quick answer

US patent 6410594 (Substituted cyclopentane compounds useful as neuraminidase inhibitors) held by BioCryst Pharmaceuticals, Inc. expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
BioCryst Pharmaceuticals, Inc.
Grant date
Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61P, A61P31/00, A61P31/16